2023-07-27 21:45:52
Title: Controversial Weight Loss Drugs Linked to Stomach Paralysis and Other Side Effects
Introduction:
Since the popularity of weight loss drugs Wegovy and Ozempic soared, reports of concerning side effects have emerged. Originally developed to treat diabetes, these medications have gained acceptance as weight loss aids. However, many users are now expressing regret after experiencing stomach paralysis and other severe symptoms.
The Link between Ozempic and Stomach Paralysis:
Ozempic and Wegovy, both semaglutides, work by imitating the natural hormone GLP-1, which helps regulate insulin production. These drugs slow down the passage of food through the stomach, leading to a feeling of fullness for longer periods. Unfortunately, some individuals have found that these medications can excessively slow gastric emptying, resulting in a condition known as gastroparesis or stomach paralysis. One sufferer, Joanie Knight from Louisiana, described her experience with Ozempic as a nightmare, regretting ever using the drug.
The Impact of Gastroparesis:
Gastroparesis is a condition characterized by delayed or halted movement of food from the stomach to the small intestine. It predominantly affects women, with doctors often unable to determine the cause in over 50% of cases. Patients, like Knight, have reported distressing symptoms such as foul-smelling belching and debilitating vomiting episodes. Medical examinations revealed that their stomachs retained food from days earlier, an abnormality compared to the usual digestion process.
Similar Cases and FDA Acknowledgement:
Medical professionals have reported numerous cases resembling Knight’s experience, leading to an increase in emergency room admissions. The US Food and Drug Administration (FDA) has also acknowledged these reports, although they have yet to confirm if gastroparesis is solely caused by the weight-loss drugs. Nevertheless, the agency has shared that some cases of gastroparesis did not resolve even after stopping the drug.
Side Effects and Lack of Warning:
Clinical trials of Wegovy found that 44% of patients experienced nausea and almost 25% reported vomiting. Ozempic users reported feeling sick and instances of vomiting in 20% and 10% of patients, respectively. Remarkably, current medication labels fail to mention the potential of developing gastroparesis.
Novo Nordisk’s Response:
Novo Nordisk, the manufacturer of Ozempic and Wegovy, stated that these drugs have undergone extensive real-world and clinical studies. They emphasize that gastrointestinal reactions, including delayed gastric emptying, nausea, and vomiting, are known side effects of the GLP-1 class. However, doctors have started warning about other potential side effects, such as blurred vision, kidney failure, gallstones, and hair loss, which have been reported by patients.
Conclusion:
The use of diabetes drugs, Ozempic and Wegovy, for weight loss purposes has recently become controversial due to emerging side effects. Stomach paralysis, or gastroparesis, has been linked to these medications, causing distressing symptoms and hospitalizations. The FDA is still investigating the connection between the drugs and gastroparesis while urging caution. Patients considering these drugs for weight loss should be aware of the potential risks, including the possibility of unknown and severe side effects.]
#weight #loss #injection #woman #longer #digest #food #health